Zoetis expands NE plant, plans HQ move; Prommune tests H1N1 vaccine for pigs; Veterinary orthopedics on the rise;

> Zoetis ($ZTS), which is in the midst of a cost-cutting program, is planning to move its New Jersey headquarters from Florham Park to another town in the same state, Parsippany, a local paper reports. The company also announced it has completed a 19,000-square-foot expansion of its manufacturing center in Lincoln, NE. Article | Release

> A vaccine developed by Prommune to prevent the pig influenza virus H1N1 will enter pivotal studies this month and could be available to hog farmers by the end of the year. Release

> A report released by Decision Resources finds that the U.S. market for veterinary orthopedics is growing faster than the European market, largely because of a higher degree of specialization by American vets and the rise of pet insurance, which is allowing more pet owners to opt for pricey procedures. Release

> Researchers from the University of Pennsylvania and Baylor College of Medicine have published a paper describing their use of advanced imaging techniques to show how a dramatic drop in insulin-producing beta cells governs the development of type 1 diabetes in dogs. Release

> A team of graduates of Oklahoma State University has launched Dem Bones, a company that's producing 3D-printed canine skeletons to serve as models for veterinary students. Article

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…